Stay updated on PD1-Vaxx B-Cell Immunotherapy in Lung Cancer Clinical Trial

Sign up to get notified when there's something new on the PD1-Vaxx B-Cell Immunotherapy in Lung Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the PD1-Vaxx B-Cell Immunotherapy in Lung Cancer Clinical Trial page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    12 days ago
    No Change Detected
  3. Check
    19 days ago
    Change Detected
    Summary
    Terminated status was added to the study record history, and new sections Oversight, Study Status, and Study Identification were introduced. The previous Active, not recruiting status and related status details were removed.
    Difference
    1%
    Check dated 2026-03-25T21:05:30.000Z thumbnail image
  4. Check
    26 days ago
    Change Detected
    Summary
    A new revision v3.5.0 was added to the Record History, and the previous revision v3.4.3 was removed.
    Difference
    0.1%
    Check dated 2026-03-18T18:00:14.000Z thumbnail image
  5. Check
    33 days ago
    Change Detected
    Difference
    0.1%
    Check dated 2026-03-11T17:14:44.000Z thumbnail image
  6. Check
    62 days ago
    Change Detected
    Summary
    A new revision entry (v3.4.2) was added, and outdated notices about funding and operating status (including v3.4.1) were removed. These updates concern the site’s version history and notices rather than the study details.
    Difference
    0.7%
    Check dated 2026-02-11T01:24:38.000Z thumbnail image
  7. Check
    69 days ago
    Change Detected
    Summary
    A government funding status notice was added to the page. The latest record revision is v3.4.1, and the previous revision v3.4.0 was deleted.
    Difference
    1%
    Check dated 2026-02-03T23:07:47.000Z thumbnail image
  8. Check
    76 days ago
    Change Detected
    Summary
    Added a glossary display option and color-coded legends for additions and deletions; included guidance on change highlighting, and updated the revision tag from v3.3.4 to v3.4.0 with No FEAR Act wording adjustment.
    Difference
    0.9%
    Check dated 2026-01-27T21:15:07.000Z thumbnail image

Stay in the know with updates to PD1-Vaxx B-Cell Immunotherapy in Lung Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the PD1-Vaxx B-Cell Immunotherapy in Lung Cancer Clinical Trial page.